CoChat

Pseudomonas aeruginosa: Recent Advances in Vaccine Development

Killough, Matthew, Rodgers, Aoife, Ingram, Rebecca · 2022 · Vaccines
Cited by 93

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Abstract

Pseudomonas aeruginosa is an important opportunistic human pathogen. Using its arsenal of virulence factors and its intrinsic ability to adapt to new environments, P. aeruginosa causes a range of complicated acute and chronic infections in immunocompromised individuals. Of particular importance are burn wound infections, ventilator-associated pneumonia, and chronic infections in people with cystic fibrosis. Antibiotic resistance has rendered many of these infections challenging to treat and novel therapeutic strategies are limited. Multiple clinical studies using well-characterised virulence factors as vaccine antigens over the last 50 years have fallen short, resulting in no effective vaccination being available for clinical use. Nonetheless, progress has been made in preclinical research, namely, in the realms of antigen discovery, adjuvant use, and novel delivery systems. Herein, we briefly review the scope of P. aeruginosa clinical infections and its major important virulence factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/vaccines10071100

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 8

  1. Olejnickova, 2014, Catheter-related infections caused by Pseudomonas aeruginosa: Virulence factors involved and their relationships, Pathog. Dis., 72, 87
  2. Costas, 2016, Specific immune response against Pseudomonas aeruginosa and haemophilus influenzae in severe COPD, Eur. Respir. J., 48, OA1790
  3. Crowe, 1991, The First Clinical Trial of Immuno’s Experimental Pseudomonas aeruginosa Flagellar Vaccines, Pseudomonas Aeruginosa Hum. Dis., 44, 143
  4. Pfeiffer, 1995, Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals, Am. J. Respir. Crit. Care Med., 151, 983
  5. Cripps, 1997, Vaccine strategies against Pseudomonas aeruginosa infection in the lung, Behring Inst. Mitt., 98, 262
  6. Kiyono, H., and Pascual, D.W. (2020). Mucosal Vaccines, Academic Press. [2nd ed.].
  7. Najafzadeh, 2021, Immunological Properties of Exotoxin A Toxoid—Detoxified Lipopolysaccharide—Gold Nanoparticles Conjugate Against Pseudomonas aeruginosa Infection, Iran. J. Immunol., 18, 292
  8. Azimi, 2021, Immunization against Pseudomonas aeruginosa using Alg-PLGA nano-vaccine, Iran. J. Basic Med Sci., 24, 476

Cited by

See all 93

Metadata

Authors
Killough, M., Rodgers, A., & Ingram, R.
Venue
Vaccines
Publisher
MDPI AG
Published
2022-07-08
Volume
10
Issue
7
Pages
1100
ISSN
2076-393X
Cited by
93
References
115
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.